SynthesisBMC musculoskeletal disorders2026
High tibial osteotomy versus unicompartmental knee arthroplasty for medial compartment knee osteoarthritis: a comprehensive meta-analysis with patient-specific stratification by age, BMI, and preoperative activity levels.
Synthesis in BMC musculoskeletal disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Author's reply to the Letters regarding 'Selecting between UKA and HTO in the grey zone'.Journal of orthopaedic translation · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe optimal surgical intervention for medial compartment knee osteoarthritis (MCOA) in active patients remains contentious. High tibial osteotomy (HTO) and unicompartmental knee arthroplasty (UKA) represent the two primary surgical options, yet evidence-based guidance for patient-specific treatment selection is lacking.
objectiveTo conduct a comprehensive meta-analysis comparing HTO versus UKA for MCOA, with stratification by age, body mass index (BMI), and preoperative activity levels to establish evidence-based patient selection criteria.
methodsA systematic search of PubMed, Embase, Cochrane Library, and Web of Science was performed from inception through December 2025. Randomized controlled trials (RCTs) and high-quality comparative observational studies were included. Primary outcomes included revision rate and Knee Society Score (KSS). Secondary outcomes encompassed WOMAC score, Tegner activity score, range of motion (ROM), and complication rates. Random-effects models with DerSimonian-Laird estimators were employed. Subgroup analyses were stratified by age (< 60 vs. ≥ 60 years), BMI (< 27 vs. ≥ 27 kg/m²), and activity level (high vs. low).
resultsTen studies comprising 860 patients (375 HTO, 485 UKA) met inclusion criteria. HTO demonstrated significantly higher revision rates (OR = 1.74, 95% CI: 1.37–2.21, P = 0.0007; I²=0.0%) and complication rates (OR = 1.77, 95% CI: 1.45–2.15, P = 0.0001) compared with UKA. UKA showed superior KSS knee scores (MD = − 3.07, 95% CI: −4.52 to − 1.63, P = 0.0012) and WOMAC outcomes (MD = 4.85, 95% CI: 4.13–5.57, P < 0.0001). Conversely, HTO demonstrated significantly better KSS function scores (MD = 3.74, 95% CI: 1.37–6.11, P = 0.0065), Tegner activity scores (MD = 0.87, 95% CI: 0.50–1.23, P = 0.0011), and ROM (MD = 11.47°, 95% CI: 8.07–14.87, P < 0.0001). Subgroup analyses revealed that younger patients (< 60 years) with high preoperative activity levels derived greater functional benefits from HTO, whereas older patients (≥ 60 years) with lower activity demands achieved superior pain relief with UKA.
conclusionsBoth HTO and UKA represent viable treatment options for MCOA with distinct outcome profiles. Current evidence suggests that UKA may provide superior pain relief and lower complication rates, while HTO appears to offer better functional outcomes and activity restoration. Preliminary subgroup analyses indicate that patient selection may be optimized based on age, activity demands, and treatment priorities, although these findings require prospective validation. LEVEL OF EVIDENCE: Level II.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.